BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 38443409)

  • 1. Investigating the mechanisms underlying resistance to chemoterapy and to CRISPR-Cas9 in cancer cell lines.
    Tomasi F; Pozzi M; Lauria M
    Sci Rep; 2024 Mar; 14(1):5402. PubMed ID: 38443409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR: The Multidrug Resistance Endgame?
    Shukla A; Jani N; Polra M; Kamath A; Patel D
    Mol Biotechnol; 2021 Aug; 63(8):676-685. PubMed ID: 34021472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Drug Resistance Mechanisms Using Genome-Wide CRISPR-Cas9 Screens.
    MacLeod G; Rajakulendran N; Angers S
    Methods Mol Biol; 2022; 2535():141-156. PubMed ID: 35867229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
    Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
    Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy.
    Chu CY; Lee YC; Hsieh CH; Yeh CT; Chao TY; Chen PH; Lin IH; Hsieh TH; Shih JW; Cheng CH; Chang CC; Lin PS; Huang YL; Chen TM; Yen Y; Ann DK; Kung HJ
    Theranostics; 2021; 11(8):3624-3641. PubMed ID: 33664852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens.
    Hart T; Tong AHY; Chan K; Van Leeuwen J; Seetharaman A; Aregger M; Chandrashekhar M; Hustedt N; Seth S; Noonan A; Habsid A; Sizova O; Nedyalkova L; Climie R; Tworzyanski L; Lawson K; Sartori MA; Alibeh S; Tieu D; Masud S; Mero P; Weiss A; Brown KR; Usaj M; Billmann M; Rahman M; Constanzo M; Myers CL; Andrews BJ; Boone C; Durocher D; Moffat J
    G3 (Bethesda); 2017 Aug; 7(8):2719-2727. PubMed ID: 28655737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer.
    Vaghari-Tabari M; Hassanpour P; Sadeghsoltani F; Malakoti F; Alemi F; Qujeq D; Asemi Z; Yousefi B
    Cell Mol Biol Lett; 2022 Jun; 27(1):49. PubMed ID: 35715750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor immune microenvironment lncRNAs.
    Park EG; Pyo SJ; Cui Y; Yoon SH; Nam JW
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34891154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to a CRISPR-based gene drive at an evolutionarily conserved site is revealed by mimicking genotype fixation.
    Fuchs S; Garrood WT; Beber A; Hammond A; Galizi R; Gribble M; Morselli G; Hui TJ; Willis K; Kranjc N; Burt A; Crisanti A; Nolan T
    PLoS Genet; 2021 Oct; 17(10):e1009740. PubMed ID: 34610011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pluripotent Stem Cells: Cancer Study, Therapy, and Vaccination.
    Barati M; Akhondi M; Mousavi NS; Haghparast N; Ghodsi A; Baharvand H; Ebrahimi M; Hassani SN
    Stem Cell Rev Rep; 2021 Dec; 17(6):1975-1992. PubMed ID: 34115316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.
    Cao W; Chen HD; Yu YW; Li N; Chen WQ
    Chin Med J (Engl); 2021 Mar; 134(7):783-791. PubMed ID: 33734139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gprofiler2 -- an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler.
    Kolberg L; Raudvere U; Kuzmin I; Vilo J; Peterson H
    F1000Res; 2020; 9():. PubMed ID: 33564394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer research needs a better map.
    Boehm JS; Garnett MJ; Adams DJ; Francies HE; Golub TR; Hahn WC; Iorio F; McFarland JM; Parts L; Vazquez F
    Nature; 2021 Jan; 589(7843):514-516. PubMed ID: 33500573
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.